Human Siglec-3 / CD33 Protein, His Tag (MALS verified)

Customer Reviews
Cat. No. / Size
Price
Qty
CD3-H5226-100ug
$395.00
CD3-H5226-1mg (250ug X 4)
$2490.00
ETA of in-stock products:2 business days

Product Details

  • Synonyms

    CD33, SIGLEC3, gp67

  • Source

    Human Siglec-3, His Tag (CD3-H5226) is expressed from human 293 cells (HEK293). It contains AA Asp 18 - His 259 (Accession # AAH28152.1).

    Predicted N-terminus: Asp 18

    Request for sequence
  • Molecular Characterization

    Siglec-3 Structure

    Other Tags and Version Biotin & Other Labeled Version

    This protein carries a polyhistidine tag at the C-terminus.

    The protein has a calculated MW of 27.6 kDa. The protein migrates as 43-55 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE) due to glycosylation.

  • Endotoxin

    Less than 0.1 EU per μg by the LAL method / rFC method.

  • Purity

    >95% as determined by SDS-PAGE.

    >95% as determined by SEC-MALS.

  • Formulation

    Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.

    Contact us for customized product form or formulation.

  • Reconstitution

    Please see Certificate of Analysis for specific instructions.

    For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

  • Storage

    For long term storage, the product should be stored at lyophilized state at -20°C or lower.

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. -20°C to -70°C for 12 months in lyophilized state;
    2. -70°C for 3 months under sterile conditions after reconstitution.
  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

Customers Also Viewed

Performance Data

  • SDS-PAGE

    Siglec-3 SDS-PAGE

    Human Siglec-3, His Tag on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 95% (With Star Ribbon Pre-stained Protein Marker).

  • SEC-MALS

    Siglec-3 SEC-MALS

    The purity of Human Siglec-3, His Tag (Cat. No. CD3-H5226) is more than 95% and the molecular weight of this protein is around 55-70 kDa verified by SEC-MALS.

    Report
  • Bioactivity-ELISA

     Siglec-3 ELISA

    Immobilized Anti-Human CD33 MAb, Mouse IgG1 at 1 μg/mL (100 μL/well) can bind Human Siglec-3, His Tag (Cat. No. CD3-H5226) with a linear range of 0.1-2 ng/mL (QC tested).

    Protocol
  •  Siglec-3 ELISA

    Immobilized Human Siglec-3, His Tag (Cat. No. CD3-H5226) at 1 μg/mL (100 μL/well) can bind Lintuzumab with a linear range of 0.06-1 ng/mL (Routinely tested).

    Protocol
  • Bioactivity-BLI

     Siglec-3 BLI

    Loaded Anti-Human CD33 MAb, Mouse IgG1 on AMC Biosensor, can bind Human Siglec-3, His Tag (Cat. No. CD3-H5226) with an affinity constant of 1.86 nM as determined in BLI assay (ForteBio Octet Red96e) (Routinely tested).

    Protocol

Customer Reviews
Writing Reviews

Background

Myeloid cell surface antigen CD33 is also known as SIGLEC3, Siglecs (sialic acid binding Ig­like lectins) and GP67, is a single-pass type I membrane protein which belongs to the immunoglobulin superfamily and SIGLEC (sialic acid binding Ig-like lectin) family. Human CD33 / Siglec-3 cDNA encodes a 364 amino acid (aa) polypeptide with a hydrophobic signal peptide, an N-­terminal Ig-­like V­-type domain, one Ig­-like C2-­type domains, a transmembrane region and a cytoplasmic tail. CD33 / Siglec-3 usually considered myeloid-specific, but it can also be found on some lymphoid cells. In the immune response, CD33 / Siglec-3 may act as an inhibitory receptor upon ligand induced tyrosine phosphorylation by recruiting cytoplasmic phosphatase(s) via their SH2 domain(s) that block signal transduction through dephosphorylation of signaling molecules. CD33 / Siglec-3 induces apoptosis in acute myeloid leukemia.

Recent Advances

 
Drug Development Progress
  • English Name:

    Myeloid cell surface antigen CD33

  • Category:

  • Approved Drugs:

    1 Details

  • Drugs in Clinical Trials:

    44 Details

  • Highest Development Stage:

    Approved

Drug Candidate Licensing
More
  • Basic Product Information
  • Product Details
  • Customers Also Viewed
  • Performance Data
  • Customer Reviews
  • Background